NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma: To better understand these different profiles, we evaluated the most common dysregulated pathways in CTCL: NF‐κB, JAK–STAT and TCR signalling pathways [49] (Figure 3C).